Human medicines European public assessment report (EPAR): Inluriyo, imlunestrant, Date of authorisation: 09/01/2026, Revision: 1, Status: Authorised

Submitted by Anonymous (not verified) on 23 February 2026 - 16:25

Human medicines European public assessment report (EPAR): Inluriyo, imlunestrant, Date of authorisation: 09/01/2026, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR): Efmody, hydrocortisone, Date of authorisation: 27/05/2021, Revision: 9, Status: Authorised

Submitted by Anonymous (not verified) on 23 February 2026 - 16:20

Human medicines European public assessment report (EPAR): Efmody, hydrocortisone, Date of authorisation: 27/05/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Ogivri, trastuzumab, Date of authorisation: 12/12/2018, Revision: 13, Status: Authorised

Submitted by Anonymous (not verified) on 23 February 2026 - 16:12

Human medicines European public assessment report (EPAR): Ogivri, trastuzumab, Date of authorisation: 12/12/2018, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 3, Status: Authorised

Submitted by Anonymous (not verified) on 23 February 2026 - 15:50

Human medicines European public assessment report (EPAR): Emblaveo, aztreonam,avibactam, Date of authorisation: 22/04/2024, Revision: 3, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More